It’s Nurse Practitioners Week, and today, we have a special episode to highlight a historic moment in time.

On November 11, the FDA changed the labeling on hormone replacement therapy. 

Join me for a short, focused episode where I read a recently published JAMA article detailing those changes, to keep you up to date on this significant development.

IN THIS EPISODE, YOU WILL LEARN:

How recent FDA updates are changing menopausal hormone therapy

The history of estrogen’s role in heart and bone health

How past research sparked fear around hormone therapy

What the new labeling means for patients and prescribers

How individualized treatment is reshaping dosage and timing decisions.

Updated FDA labeling now distinguishes between systemic and topical therapies

Key considerations for menopause-related urinary and genital health

How these updates will potentially impact women’s long-term health

Connect with Cynthia Thurlow  

Follow on X, Instagram & LinkedIn

Check out Cynthia’s website

Submit your questions to [email protected]